Expression of Glucosylceramide Synthase, Converting Ceramide to Glucosylceramide, Confers Adriamycin Resistance in Human Breast Cancer Cells
Open Access
- 1 January 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (2) , 1140-1146
- https://doi.org/10.1074/jbc.274.2.1140
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Up-regulation of Glucosylceramide Synthase Expression and Activity during Human Keratinocyte DifferentiationJournal of Biological Chemistry, 1998
- Alteration of the Sphingomyelin/Ceramide Pathway Is Associated with Resistance of Human Breast Carcinoma MCF7 Cells to Tumor Necrosis Factor-α-mediated CytotoxicityPublished by Elsevier ,1997
- Ceramide signaling in apoptosisBritish Medical Bulletin, 1997
- Ceramide: A Novel Lipid Mediator of ApoptosisPublished by Elsevier ,1997
- Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer CellsJournal of Biological Chemistry, 1997
- Sphingomyelin breakdown and cell fateTrends in Biochemical Sciences, 1996
- Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced ApoptosisCell, 1996
- Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis.Proceedings of the National Academy of Sciences, 1996
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Functions of Sphingolipids and Sphingolipid Breakdown Products in Cellular RegulationScience, 1989